Benign prostatic hyperplasia drugs and surgeries do not treat enlarged prostate, unlike Dr Allen’s Device

Benign prostatic hyperplasia drugs and surgeries do not treat enlarged prostate, unlike Dr Allen’s Device

Dr Allen’s Device is the only safe treatment to reduce the size of an enlarged prostate in men with benign prostatic hyperplasia (BPH) eliminating lower urinary tract symptoms (LUTS).

BPH is diagnosed in about 50% of men over 50. The incidence of prostate enlargement increases with age, reaching 90 percent in men over 80. However, BPH is not cancer and requires careful and safe treatment in the first place.

The effectiveness and safety of the prostate treatment with Dr Allen’s Device has been proven in the controlled clinical trials. According to a scientific article:

“Innovative Thermobalancing therapy and Dr Allen’s Device for the first time employ body energy to treat chronic prostatic diseases effectively”

published in the leading medical journal, this device utilises the naturally emitted body heat for reducing the abnormal size of the enlarged prostate.

Thermobalancing therapy with Dr Allen’s Device received a patent issued by the US Patent and Trademark Office, confirming the uniqueness of this treatment for BPH.

 

Standard treatment options for BPH should be reassessed

Standard management for BPH are drugs and a number of surgeries. An article published recently by Fogaing “Is early surgical treatment for benign prostatic hyperplasia preferable to prolonged medical therapy: pros and cons” discusses BPH drugs and surgeries, as right treatment options for men with BPH.

Physicians believe that with the help of drug therapy, men can avoid the serious risks inherent in BPH surgery, including serious side effects for sex. Surgeons emphasized the higher efficiency and cost-effectiveness of surgical interventions compared with the use of BPH drugs, and the possibility of worsening postoperative results if surgical treatment is delayed.

See also  Array

Standard treatment options, BPH drugs and surgeries have side effects, including sexual and erectile dysfunction, impotence, diabetes, which can cause additional mental health problems and depression.

At-home use of Dr Allen’s Device does not require drugs and surgeries

Dr Allen’s Device has been registered with the Medical Regulatory Healthcare Agency in Great Britain since 2010, as a class 1 medical device that cannot harm. So, its safety is confirmed over the decade.

However, urologists are reluctant to tell their patients about this safe prostate treatment in competition with risky medications and surgeries.

The Aging Male journal published the article

“Use of Thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology”

which explains that Dr Allen’s Device treats the cause of BPH, and Thermobalancing treatment improves blood circulation in the affected prostate, reducing enlargement of the prostate and urinary symptoms dramatically, without dugs and surgeries.

 

Fine Treatment produces and distributes Dr Allen’s Device.

Thermobalancing treatment is used by people at home for over ten years successfully. The use of Dr Allen’s Device at home is important as it protects men from visiting clinics and hospitals, which are the most dangerous place for contracting a coronavirus infection.

Fine Treatment manufactures Dr Allen’s Devices in the United Kingdom and makes them available worldwide, with free international delivery currently on offer. Thousands of Fine Treatment’s customers across 100 countries have already benefited from this powerful and safe Thermobalancing therapy without BPH drugs and surgeries.

 

By Chris Skeldon

"Coffee trailblazer. Social media ninja. Unapologetic web guru. Friendly music fan. Alcohol fanatic."